Disodium ascorbyl phytostanol phosphate. A new cholesterol-lowering drug? K. von Bergmann Editorial Commentary 06 May 2008 Pages: 649 - 650
Efficacy and safety of disodium ascorbyl phytostanol phosphates in men with moderate dyslipidemia Maud N. VissersMieke D. TripJohn J. P. Kastelein Clinical Trial Open access 05 March 2008 Pages: 651 - 661
Impact of genetic polymorphisms of leptin and TNF-α on rosiglitazone response in Chinese patients with type 2 diabetes Hai-Ling LiuYang-Gen LinZhao-Qian Liu Pharmacogenetics 26 April 2008 Pages: 663 - 671
Association of slow N-acetyltransferase 2 profile and anti-TB drug-induced hepatotoxicity in patients from Southern Brazil L. G. PossueloJ. A. CastelanA. Zaha Pharmacogenetics 18 April 2008 Pages: 673 - 681
Pharmacokinetics and tolerability of artesunate and amodiaquine alone and in combination in healthy volunteers Catherine OrrellFrancesca LittleKaren I. Barnes Pharmacokinetics and Disposition Open access 16 April 2008 Pages: 683 - 690
The effect of fluvoxamine on the pharmacokinetics, safety, and tolerability of ramosetron in healthy subjects Takeshi KadokuraMartin den AdelAkito Nishida Pharmacokinetics and Dispossition 26 April 2008 Pages: 691 - 695
Effect of the novel antipsychotic drug perospirone on P-glycoprotein function and expression in Caco-2 cells Yan-Gang ZhouKun-Yan LiHuan-De Li Pharmacokinetics and Disposition 14 May 2008 Pages: 697 - 703
How many subjects are necessary for population pharmacokinetic experiments? Confidence interval approach Kayode OgungbenroLeon Aarons Pharmacokinetics and Disposition 16 May 2008 Pages: 705 - 713
Factors predicting hospital readmissions related to adverse drug reactions Borja RuizMontserrat GarcíaCarmelo Aguirre Pharmacoepidemiology and Prescription 03 April 2008 Pages: 715 - 722
Safety aspects of iodinated contrast media related to their physicochemical properties: a pharmacoepidemiology study in two Tuscany hospitals Francesco LapiEnrica CecchiAlessandro Mugelli Pharmacoepidemiology and Prescription 10 April 2008 Pages: 723 - 737
A reversible coma after oxaliplatin administration suggests a pathogenetic role of electrolyte imbalance Michele BassoAlessandra CassanoCarlo Barone Letter to the Editors 19 March 2008 Pages: 739 - 741